Profile picture

Doctor Yanish Purmah

Sandwell and West Birmingham Hospitals NHS Trust, Birmingham (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Identifying the value of RVEF for the prediction of major cardiovascular outcomes: a study of 7,131 patients undergoing cardiovascular magnetic resonance imaging
Presentation
Identifying the value of RVEF for the prediction of major cardiovascular outcomes: a study of 7,131 patients undergoing cardiovascular magnetic resonance imaging
Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy
Presentation
Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy
Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.
Presentation
Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.
Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry
Presentation
Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry
A pilot study analysing different plasma biomarkers in patients with and without atrial fibrillation identifies fibroblast growth factor 23.
Presentation
A pilot study analysing different plasma biomarkers in patients with and without atrial fibrillation identifies fibroblast growth factor 23.
Evolution of symptoms, rate, and rhythm control therapy in AF patients in Europe: a comparison of the PREFER in AF and PREFER in AF prolongation data sets.
Presentation
Evolution of symptoms, rate, and rhythm control therapy in AF patients in Europe: a comparison of the PREFER in AF and PREFER in AF prolongation data sets.

ESC 365 is supported by